Brookfield Corp’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-27,627
| Closed | -$696K | – | 685 |
|
|
2022
Q1 | $696K | Buy |
+27,627
| New | +$696K | ﹤0.01% | 516 |
|
|
2021
Q2 | – | Sell |
-11,438
| Closed | -$348K | – | 599 |
|
|
2021
Q1 | $348K | Sell |
11,438
-5,430
| -32% | -$165K | ﹤0.01% | 426 |
|
|
2020
Q4 | $334K | Buy |
+16,868
| New | +$334K | ﹤0.01% | 415 |
|